Improving Sleep in a Psychiatric Hospital

Comparative Effectiveness Trial of Sleep Promotion vs. Disruption in High Suicide Risk Inpatients

The purpose of this study is to examine effects of sleep promotion versus treatment as usual (TAU) on subjective, self-reported sleep while in inpatient psychiatric treatment, to examine effects of sleep promotion vs. TAU/sleep disruption on self-reported depression, anxiety, suicide risk across inpatient length of stay, readmission at 72 hours, objective sleep and to compare implementation outcomes of acceptability and feasibility of sleep promotion relative to TAU/sleep disruption as reported by patients, clinicians, and clinic leaders using mixed methods.

Inclusion Criteria:

• Admitted voluntarily to inpatient psychiatric hospital for suicidal ideation or behavior.
• Continue to express suicide risk on the Suicide Behaviors Questionnaire-Revised (SBQ-R) of ≥8 at admission.
• Cognitive ability as tested by the Montreal Cognitive Assessment (MoCA) of > 23.
• Have sufficient communication and comprehension ability to consent to the study
• English speaking

Exclusion Criteria:

• Intellectual disability/unable to give informed consent.
• Patients with one-to-one supervision or 15-minute (Q15) safety checks for suicidality or aggression will be unable to enroll in the study until these restrictions are discontinued.
• Patients with roommates that are on one-to-one supervision or Q15 safety checks for suicidality or aggression.
• Patients enrolled in the study with a patient admitted as their roommate who requires one-to-one supervision or Q15 checks-Patient will be unenrolled if a room change is not possible.